Business
UK pharma giant GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion
GSK Plc is set to acquire Nuvalent for $10.6 billion, paying $124 per share. The move aims to boost GSK's oncology treatments.
GSK Plc is set to acquire Nuvalent for $10.6 billion, paying $124 per share. The move aims to boost GSK's oncology treatments.
The Bharat Citizen news desk is following the story and will update this page as more verified details become available.
Readers are advised to follow official advisories and confirmed statements where the story involves public safety, government services, courts, or markets.
Quick Questions
Who publishes Bharat Citizen?
Bharat Citizen is a national Hindi weekly newspaper launched from Delhi in July 2008.
What does Bharat Citizen cover?
The newspaper focuses on politics, social issues, crime, state news, public-interest reporting, jobs, education and citizen concerns.